Topic

Articles

Vaccines define the path to putting the pandemic in the rear-view mirror.

Avoiding Delays on the Road to Normalcy

Editor of Pharmaceutical Technology Europe

Five therapeutic candidates for the treatment of COVID-19 are identified as promising by the European Commission.

Identifying Promising COVID-19 Therapies

GSK’s position is raising concerns as it continues working towards its separation of businesses.

Divest and Conquer? GSK's Future is in Question

Rita Peters is editorial director of Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.

Bio/pharmaceutical manufacturers have made a good first step toward global vaccination through pledging doses at no- to low-profit rates. 

A “We are the World” Vaccination Effort?

As face masks start to come off, bio/pharma’s COVID-19 battle goes on.

Moving Into the Next Phase

The world of bio/pharma has been celebrating its achievements across a variety of categories in the latest rounds of awards.

Acknowledging Bio/Pharma Innovation

Smart, accurate, science-based messaging is needed to advance bio/pharma science.

Avoiding Unforced Errors in the Bio/Pharma Industry

COVID-19 has placed bio/pharma in the spotlight of global media, but away from vaccines there are other prospective pipeline treatments that will be worth watching.

A Watchful Eye on Pharma: Promising Drugs and Changing Bio/Pharma Landscape

Bio/pharma works hard today to change the calendar to tomorrow.

Fighting Through This Slow Season of Change

More work is needed to ensure the rising demand for cell and gene therapy manufacturing capacity and required skilled workforce can be met in Europe.

From the Editor